Navellier & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $437K | Sell |
|
|||||
|
2024
Q3 | $14.1M | Sell |
|
|||||
|
2024
Q2 | $18M | Buy |
|
|||||
|
2024
Q1 | $14.6M | Buy |
|
|||||
|
2023
Q4 | $11.6M | Buy |
|
|||||
|
2023
Q3 | $9.56M | Sell |
|
|||||
|
2023
Q2 | $8.52M | Buy |
|
|||||
|
2023
Q1 | $4.83M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $854K | Sell |
|
|||||
|
2015
Q2 | $1.43M | Buy |
|
|||||
|
2015
Q1 | $925K | Sell |
|
|||||
|
2014
Q4 | $759K | Sell |
|
|||||
|
2014
Q3 | $858K | Buy |
|
|||||
|
2014
Q2 | $542K | Sell |
|
|||||
|
2014
Q1 | $565K | Sell |
|
|||||
|
2013
Q4 | $461K | Buy |
|
|||||
|
2013
Q3 | $350K | Sell |
|
|||||
|
2013
Q2 | $404K | Buy |
|